# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-06-2025 | 06-30-2025 | 10-Q | |
2 | 05-08-2025 | 03-31-2025 | 10-Q | |
3 | 03-24-2025 | 12-31-2024 | 10-K | |
4 | 11-12-2024 | 09-30-2024 | 10-Q | |
5 | 08-29-2024 | 06-30-2024 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Artiva Biotherapeutics, Inc. are rising Friday after the San Diego-based biotech company shared a milestone regulator...
Wedbush analyst Martin Fan maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Outperform and raises the price target fro...
CSX: 3% | CSX shares are trading higher after the company reported better-than-expected Q3 financial results. ARTV: 144% | Arti...
Needham analyst Gil Blum reiterates Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and maintains $18 price target.